Posted in | News | Nanoanalysis

Image Acquisition Software Launch for Centralized Control of NanoZoomer® MD Series

Hamamatsu Photonics proudly announces the launch of NZConnectMD Scan, U16414-0121MDEU an image acquisition platform designed to optimize digital pathology workflows with barcode-driven, centralized control of multiple S540MDs, S360MDs and S20MDs of the NanoZoomer MD Series.

NZConnectMD Scan addresses the growing demand for enhanced efficiency and flexibility in pathology laboratories. This software platform allows users to manage multiple scanners from a single interface, streamlining operations, maximizing productivity, and optimizing space within the lab.

With NZConnectMD Scan, laboratories can achieve improved workload balancing, better utilization of scanner capacity, and enhanced traceability with integrated barcode-based slide tracking and logging. The software ensures seamless integration into existing lab workflows, providing a powerful tool for labs of any size to scale their operations without disruption.

Key Features:

  • Centralized Control: Manage multiple NanoZoomer MD Series from one PC (For NanoZoomer S540MD, S360MD and S20MD)
  • Remote Access: Operate scanners from any authorized computer
  • Barcode-Based Slide Tracking: Ensure precise traceability of every slide
  • Workflow Balancing: Distribute workloads efficiently across scanners
  • Space Optimization: Reduce physical footprint by eliminating the need for a separate workstation for each NanoZoomer
  • Full Audit Trail: Maintain comprehensive logging of slide activity
  • Regulatory Compliant: IVDR, IvDO and UK MDR2002

Designed as the perfect complement to Hamamatsu's NanoZoomer MD Series, NZConnectMD Scan extends their functionality and simplifies complex workflows. By enabling a single point of control, the new software reduces bottlenecks, minimizes manual intervention, and allows laboratories to focus on delivering accurate and timely diagnoses.

Backed by Hamamatsu's commitment to quality, customer support, and regulatory compliance, NZConnectMD Scan ensures smooth adoption and integration into laboratory environments. Our team of experts provides comprehensive training and ongoing technical assistance, empowering labs to fully leverage the software's capabilities.

Hamamatsu Photonics remains dedicated to advancing digital pathology with innovative solutions that address the evolving needs of clinical laboratories. NZConnectMD Scan represents a significant step towards more connected, efficient, and scalable lab operations.

Discover the power of centralized control with NZConnectMD Scan.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hamamatsu Photonics Europe. (2025, April 09). Image Acquisition Software Launch for Centralized Control of NanoZoomer® MD Series. AZoNano. Retrieved on April 12, 2025 from https://www.azonano.com/news.aspx?newsID=41346.

  • MLA

    Hamamatsu Photonics Europe. "Image Acquisition Software Launch for Centralized Control of NanoZoomer® MD Series". AZoNano. 12 April 2025. <https://www.azonano.com/news.aspx?newsID=41346>.

  • Chicago

    Hamamatsu Photonics Europe. "Image Acquisition Software Launch for Centralized Control of NanoZoomer® MD Series". AZoNano. https://www.azonano.com/news.aspx?newsID=41346. (accessed April 12, 2025).

  • Harvard

    Hamamatsu Photonics Europe. 2025. Image Acquisition Software Launch for Centralized Control of NanoZoomer® MD Series. AZoNano, viewed 12 April 2025, https://www.azonano.com/news.aspx?newsID=41346.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.